Glenmark gets USFDA nod for skin lesion treatment gel

— September 14, 2016 comments off

The company’s current portfolio consists of 110 products authorised for distribution in the US marketplace and 61 Abbreviated New Drug Applications (ANDAs) pending approval with the USFDA, it added.